LEXARIA BIOSCIENCE CORP. Banking Regulation, Total Capital, Actual
LEXARIA BIOSCIENCE CORP. (LEXX) had Banking Regulation, Total Capital, Actual of $96.03 thousand as of 2022-11-30, per its 10-Q/A filed 2023-01-18.
Discontinued › Notes › Banking and Thrift
us-gaap:Capital · last filed 2023-01-18
- 2022-11-30: Banking Regulation, Total Capital, Actual $96.03K.
- 2022-08-31: Banking Regulation, Total Capital, Actual $96.03K.
- 2021-08-31: Banking Regulation, Total Capital, Actual $0.00.
| Period end | Banking Regulation, Total Capital, Actual |
|---|---|
| 2022-11-30 | $96.03K 10-Q/A · filed 2023-01-18 |
| 2022-08-31 | $96.03K 10-Q/A · filed 2023-01-18 |
| 2021-08-31 | $0.00 10-K · filed 2022-11-28 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Telomir Pharmaceuticals, Inc. (TELO) | United States | $0.084B | |
| NEONC TECHNOLOGIES HOLDINGS, INC. (NTHI) | United States | $0.086B | |
| ONCOLYTICS BIOTECH INC (ONCY) | $0.086B | ||
| Gain Therapeutics, Inc. (GANX) | United States | $0.080B | -4.40 |
| Rallybio Corp (RLYB) | United States | $0.089B | |
| Lifevantage Corp (LFVN) | United States | $0.078B | 15.40 |
| Adicet Bio, Inc. (ACET) | United States | $0.078B | -0.81 |
| Acrivon Therapeutics, Inc. (ACRV) | United States | $0.091B | -1.03 |
| Valion Bio, Inc. (VBIO) | United States | $0.077B | |
| MAIA Biotechnology, Inc. (MAIA) | United States | $0.077B | -2.30 |